Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging strategies in peripheral T-cell lymphoma.

Hematology. American Society of Hematology. Education Program - 6 Dec 2019

Mehta-Shah Neha

Abstract excerpt

Peripheral T-cell lymphomas (PTCLs) are a heterogenous group of aggressive non-Hodgkin lymphomas that are less chemosensitive than their B-cell counterparts. Until recently, standard therapy did not distinguish between subtypes, and deeper understanding of the biology of these diseases was lacking. The availability of targeted therapy and more sophisticated subtype classification has translated into the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Epigenome
Share to Lymphoma, T-Cell, Peripheral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Phenotype

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 31808829
DOI: 10.1182/hematology.2019000012
PMCID: PMC6913433

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging strategies in peripheral T-cell lymphoma.PMID 31808829Read ↗

Peripheral T cell lymphomas: from the bench to the clinic.Semantic proximity Read ↗

Advances in peripheral T cell lymphomas: pathogenesis, genetic landscapes and emerging therapeutic targetsSemantic proximity Read ↗

Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicabilitySemantic proximity Read ↗

Histone Deacetylase Inhibitors for Peripheral T-cell Lymphomas: From Biology to Real-World TherapySemantic proximity Read ↗

The Future of Combination Therapies for Peripheral T Cell Lymphoma (PTCL).Semantic proximity Read ↗

New insights into the biology of T-cell lymphomasSemantic proximity Read ↗

Pathogenesis of Peripheral T Cell LymphomaSemantic proximity Read ↗

Targeted based therapy in nodal T-cell lymphomas.Semantic proximity Read ↗

Pathology of peripheral T-cell lymphomas: where do we stand?Semantic proximity Read ↗

A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilitiesSemantic proximity Read ↗

T-cell Lymphomas: Updates in Biology and Diagnosis.Semantic proximity Read ↗

Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.